Automatic classification of RDoC positive valence severity with a neural network

利用神经网络自动对RDoC正效价严重程度进行分类

阅读:1

Abstract

OBJECTIVE: Our objective was to develop a machine learning-based system to determine the severity of Positive Valance symptoms for a patient, based on information included in their initial psychiatric evaluation. Severity was rated on an ordinal scale of 0-3 as follows: 0 (absent=no symptoms), 1 (mild=modest significance), 2 (moderate=requires treatment), 3 (severe=causes substantial impairment) by experts. MATERIALS AND METHODS: We treated the task of assigning Positive Valence severity as a text classification problem. During development, we experimented with regularized multinomial logistic regression classifiers, gradient boosted trees, and feedforward, fully-connected neural networks. We found both regularization and feature selection via mutual information to be very important in preventing models from overfitting the data. Our best configuration was a neural network with three fully connected hidden layers with rectified linear unit activations. RESULTS: Our best performing system achieved a score of 77.86%. The evaluation metric is an inverse normalization of the Mean Absolute Error presented as a percentage number between 0 and 100, where 100 means the highest performance. Error analysis showed that 90% of the system errors involved neighboring severity categories. CONCLUSION: Machine learning text classification techniques with feature selection can be trained to recognize broad differences in Positive Valence symptom severity with a modest amount of training data (in this case 600 documents, 167 of which were unannotated). An increase in the amount of annotated data can increase accuracy of symptom severity classification by several percentage points. Additional features and/or a larger training corpus may further improve accuracy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。